We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

FOXO3 rs12212067: What Your Genotype Means

rs12212067
Trait
Limited evidenceGene: FOXO3

FOXO3 rs12212067 is an intronic single nucleotide polymorphism located in the forkhead box O3 gene on chromosome 6. Research has linked this variant to markers of ovarian reserve and the timing of reproductive senescence, as well as the modulation of inflammatory cytokine production. While functionally intriguing, published clinical evidence for individual predictive utility remains limited.

What each genotype means

T/TLower attention

Typical ovarian reserve profile

You carry two copies of the common T allele at rs12212067 in the FOXO3 gene. This genotype is typically associated with baseline rates of primordial follicle activation and average reproductive timing parameters in population studies. Evidence linking this specific intronic variant directly to differences in ovarian reserve remains limited and preliminary.

Carried by approximately 35% to 40% of individuals of European ancestry, and represents the most common genotype in many global populations.

G/TLower attention

Intermediate ovarian reserve variation

You carry one copy of the G allele and one copy of the T allele at rs12212067. Because FOXO3 plays a critical role in preserving the dormant ovarian follicle pool, carrying this regulatory variant has been tentatively linked to slight variations in ovarian reserve markers and timing of reproductive senescence. However, scientific evidence for this specific association is limited and not diagnostic of personal fertility.

Carried by approximately 45% to 50% of individuals of European ancestry.

G/GLower attention

Altered ovarian reserve markers

You carry two copies of the minor G allele at rs12212067. Research indicates this regulatory FOXO3 polymorphism may subtly modulate gene expression related to primordial follicle maintenance and ovarian reserve lifespan. Because published evidence remains limited, these statistical observations should not be interpreted as a forecast of fertility or reproductive lifespan.

Carried by approximately 12% to 16% of individuals of European ancestry.

Genomic Location and Variant Characteristics

The single nucleotide polymorphism rs12212067 represents a single base change (commonly described as G/T) located within an intron of the FOXO3 gene on the long arm of human chromosome 6. Because it sits in non-coding intronic sequence rather than an exon, it does not alter the primary amino acid sequence of the resulting protein. Instead, research indicates it serves as an intronic regulatory polymorphism, influencing transcriptional regulation, splicing efficiency, or chromatin interactions. In human genetic studies, it is in partial linkage disequilibrium with other widely studied non-coding variants in the locus that influence cellular aging and gene expression. Because the human genome contains a highly homologous pseudogene (ZNF286B) that complicates coding analyses of FOXO3, intronic markers like rs12212067 provide reliable targets for standard genotyping platforms.

The Biological Role of the FOXO3 Gene

The FOXO3 gene encodes Forkhead Box O3 (often referred to as FOXO3a), an evolutionarily conserved transcription factor operating downstream of the insulin and insulin-like growth factor signaling (IIS) cascade. FOXO3 functions as a master regulator of cellular homeostasis, directing transcriptional programs that govern DNA repair, oxidative stress resistance, cell cycle arrest, and apoptosis. In female reproductive biology, animal models have established that FOXO3 is vital for preserving the primordial follicle pool. Knockout models show premature, unregulated follicle activation leading to early ovarian failure, whereas heightened FOXO3 activity slows follicular depletion. In the immune system, FOXO3 activity dampens excessive inflammatory cascades by modulating cytokine pathways, including the suppression of tumor necrosis factor-alpha (TNF-α) and the promotion of anti-inflammatory interleukin-10.

Ovarian Reserve and Immune System Research

Human association studies have explored rs12212067 in the context of reproductive lifespan and inflammatory regulation. In reproductive biology, statistical associations have been noted between FOXO3 variants, parameters of ovarian reserve, and the timing of reproductive senescence or natural menopause. Concurrently, molecular immunology studies published in journals such as Cell have documented that the minor allele of rs12212067 associates with altered monocyte activation and a reduced inflammatory cytokine signature, correlating with milder clinical trajectories in conditions such as rheumatoid arthritis and Crohn's disease. However, the overall clinical evidence for rs12212067 as an isolated predictor of ovarian lifespan or immune diagnosis remains classified as limited. Most observed effect sizes are modest and reflect complex polygenic interactions rather than deterministic biological shifts.

Population Distribution and Genetic Context

The minor allele of rs12212067 is relatively common in many global populations, with an estimated minor allele frequency of approximately 0.38 in individuals of European ancestry according to large genomic reference cohorts. The variant is also frequently evaluated in East Asian populations, where specific genotype distributions have been scrutinized in chronic inflammatory and autoimmune cohorts. Because allele frequencies vary between global ancestries, baseline risks and haplotype structures cannot be universally generalized across different demographic backgrounds. Furthermore, rs12212067 resides in an extensive region of linkage disequilibrium across the FOXO3 locus, meaning it often tags a larger set of co-inherited variants rather than acting entirely on its own.

What You Can and Cannot Conclude

Discovering your rs12212067 genotype provides interesting educational insight into your baseline cellular and reproductive biology, but it cannot diagnose any medical condition or accurately forecast your individual fertility window. Reproductive aging and ovarian reserve are complex polygenic traits governed by hundreds of genetic loci interacting with lifestyle factors, environmental exposures, and chronological age. A particular genotype does not guarantee early menopause, extended fertility, or autoimmune susceptibility. Genotyping at a single non-coding position cannot replace standard clinical evaluations, such as serum anti-Müllerian hormone (AMH) tests, antral follicle counts, or comprehensive rheumatology workups overseen by qualified healthcare professionals.

How common is this variant?

The minor allele occurs at an estimated frequency of approximately 0.38 in European populations, with moderate to common prevalence documented across East Asian and other global ancestral cohorts in dbSNP and gnomAD.

Frequently asked questions

Can FOXO3 rs12212067 predict when I will go through menopause?

No, this genetic variant cannot predict the timing of natural menopause or individual fertility. While research associates FOXO3 variation with primordial follicle maintenance, reproductive timing is influenced by hundreds of genetic factors and environmental exposures.

Does this variant mean I have diminished ovarian reserve?

No, carrying a specific genotype at rs12212067 does not diagnose diminished ovarian reserve or premature ovarian insufficiency. Clinical assessments of ovarian reserve rely on biomarkers such as anti-Müllerian hormone (AMH) and transvaginal ultrasound rather than single non-coding SNPs.

Is FOXO3 rs12212067 considered a longevity gene?

FOXO3 is widely known as a major gene associated with human longevity, primarily driven by intronic variants like rs2802292. Although rs12212067 is in physical proximity on the same gene, it is primarily studied for its regulatory effects on inflammation and follicular biology rather than extreme lifespan alone.

Should I change my medical treatments based on my rs12212067 genotype?

No, you should never alter any medication, fertility planning, or disease management based on direct-to-consumer genotyping results for this variant. Any clinical decisions regarding reproductive health or inflammatory therapies should be discussed directly with your physician.

Sources & further reading

Educational information only, last refreshed 9/11/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs12212067?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29